I also just listened to the conference call. These shares are...

I also just listened to the conference call.
These shares are going into the bottom draw.
No question these results are significant.
Start to be worried BNC210 works too well. Would it become abused?
Listening to the call I could imagine BNC210 in the fridge in Fire Stations for PTSD for Fire Fighters coming back from a job. Maybe I am getting ahead of myself.

Really should be focusing on how to buy more stock.
This drug has a lot of trials ahead of it. 5-6 years till it hits the market.

Motley Fool thinks Bionomics is still overpriced after these trial results:
http://www.********.au/2016/09/22/is-bionomics-ltd-the-next-medical-developments-limited/
The fools.